Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ezisurg Medical

Request full access

Produces medical instruments for minimally invasive surgery

Huangpu, ChinaFounded 2011Sports

About Ezisurg Medical

Ezisurg Medical, established in November 2011 by founder Henry Nie, is a Shanghai-based company operating in the surgical devices market. The firm is focused on the research, development, and commercialization of devices for minimally invasive surgery (MIS). Ezisurg serves hospitals, surgeons, and their patients by providing a portfolio of surgical stapling products, energy devices, and endoscopy platforms. These tools are utilized in a variety of procedures, including general, bariatric, thoracic, colorectal, and urologic surgeries.

The company's business model centers on manufacturing and selling these high-end MIS products globally. A significant milestone was achieved in March 2025 when Ezisurg's U.S. subsidiary secured a supplier agreement with Vizient, Inc., one of the largest group purchasing organizations (GPOs) in the United States, granting it access to a vast network of healthcare providers. This positions the company within the U.S. surgical staplers market, which was valued at $2.1 billion in 2023. Ezisurg's products are used in over 1,400 hospitals in China and have received entry approvals in more than 80 countries, holding numerous global certifications, including FDA approvals and CE marks.

Ezisurg's product lineup includes the easyEndo™ series of linear cutting staplers, which are notable for features such as a 60-degree articulation angle, exceeding that of some established brands, and a design enabling one-handed operation. Another key product is the easyUS™ Ultrasonic Surgical System, an advanced ultrasonic scalpel designed to simultaneously cut tissue and provide hemostasis with minimal lateral thermal damage and less smoke compared to traditional electrocautery. The company has received multiple rounds of venture capital funding from investors including Hillhouse Investment Group, BioTrack Capital, and IDG Capital to support its growth and product development.

Source: Dealroom company data

Ezisurg Medical in the Huangpu ecosystem

Live from Dealroom

The Ezisurg Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Shanghai Pudong Science and Technology Investment
  • Xiamen C&D
Employees 118 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
13 countries with
team presence
🇨🇳 China58.9%
🇪🇬 Egypt10.7%
🇮🇳 India7.1%
🇺🇸 United States3.6%
🇦🇪 United Arab Emirates3.6%
Top 5 of 13 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Ezisurg Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ezisurg Medical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.